Powered by Roundtable

Marlins No. 47 prospect Aiva Arquette will miss 4–6 weeks after core muscle surgery. What it means for his 2026 development timeline.

The Miami Marlins will be without one of their most important young infielders for at least the next month after Aiva Arquette underwent core muscle surgery on Friday in Philadelphia.

According to MLB.com’s Christina De Nicola, Arquette is expected to miss 4-6 weeks following the procedure.

The 22-year-old arrived in Jupiter this spring already dealing with a lingering left groin issue suffered during offseason workouts in Hawaii. While he initially shut down activities to rest, discomfort resurfaced when he ramped back up at the Marlins’ Jupiter Academy, prompting further evaluation and a recommendation for surgery.

For Miami, this isn’t just a routine spring setback. Arquette, selected seventh overall in the 2025 draft, represents a significant part of the organization’s long-term infield plans. Ranked No. 47 overall by MLB Pipeline, he is one of the highest-upside position players in a system that has leaned heavily on pitching depth in recent years.

On paper, four to six weeks doesn’t sound catastrophic. In the grand scheme of a 162-game season and a multi-year development arc, it’s manageable. But for a first-rounder entering his first full professional season, every at-bat matters.

Arquette debuted at High-A Beloit late last year, hitting .242/.350/.323 across 27 games. The slash line wasn’t eye-popping, but the underlying plate discipline -- a .350 on-base percentage in his first taste of pro ball -- offered a glimpse of the polished offensive approach that made him a top-10 selection.

The real loss here is repetition. Arquette needs defensive innings at shortstop, exposure to upper-level velocity, and consistency in his daily routine. Core muscle injuries can sap rotational strength, which directly impacts both power output and lateral movement in the field. Even after he returns, there may be a brief recalibration period as he regains full explosiveness.

The Marlins have emphasized athleticism and up-the-middle talent under their current development model. Arquette fits that blueprint perfectly -- a smooth defender with projectable power and advanced strike-zone awareness.

If recovery goes smoothly, he could still open the year in High-A or potentially push toward Double-A by midseason. The organization will likely prioritize long-term health over aggressive promotion.

In a system counting on its 2025 draft class to infuse position-player upside, Arquette’s health is paramount. The good news: core muscle procedures have become increasingly routine in baseball, with many players returning at full strength.

For now, development pauses. But if all goes according to plan, this should be a temporary detour for one of Miami’s most important prospects.

Join our ROUNDTABLE community! It's completely free to join. Share your thoughts, engage with our Roundtable writers, and chat with fellow members.

Download the free Roundtable APP, and stay even more connected!